# Th Tl Xb Prescription on Reprogramming of Lipid Metabolism and Endothelial Injury for Cerebral Infarction Patients

> **NCT06549582** · NA · NOT_YET_RECRUITING · sponsor: **Yan Zhu** · enrollment: 160 (estimated)

## Conditions studied

- Cerebral Infarction
- Chinese Herbal Medicine
- Clinical Trial
- Lipid Metabolism Disorder
- Endothelial Injury

## Interventions

- **OTHER:** Taohong Tongluo Xiaoban Prescription
- **OTHER:** Fundamental medical treatment

## Key facts

- **NCT ID:** NCT06549582
- **Lead sponsor:** Yan Zhu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10
- **Primary completion:** 2026-07
- **Final completion:** 2026-12
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2024-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06549582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06549582, "Th Tl Xb Prescription on Reprogramming of Lipid Metabolism and Endothelial Injury for Cerebral Infarction Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06549582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*